Principal Investigator
Juan Carlos Ramos
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231198
Clinical Trial Summary
A Phase 2 Trial of Ixazomib for Kaposi Sarcoma
Phase
Phase II
Funding Agency/Sponsor
National Cooperative Group
Disease
Lymphoma
Contact Information
Phone Number
305-243-2647